A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4412 (2006.01)
Patent
CA 2667654
The invention relates to methods for decreasing adverse events associated with pirfenidone (5-methyl-l-phenyl-2-(lH)-pyridone) therapy. The invention discloses an optimized dose escalation scheme that results in the patient having increased tolerance to adverse events associated with the administration of pirfenidone. The invention also discloses a starter pack that may be used in conjunction with the dose escalation scheme.
L'invention concerne des procédés qui permettent de réduire les effets secondaires associés à la thérapie par le Pirfenidone (5-méthyl-l-phényl-2-(lH)-pyridone). L'invention se rapporte à un mécanisme d'escalade de doses optimisé qui permet d'obtenir chez un patient une tolérance augmentée aux effets secondaires associés à l'administration du Pirfenidone. L'invention porte également sur un échantillon de départ qui peut être utilisé avec le mécanisme d'escalade de doses précité.
Intermune Inc.
Smart & Biggar
LandOfFree
Method of providing pirfenidone therapy to a patient does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of providing pirfenidone therapy to a patient, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of providing pirfenidone therapy to a patient will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2021067